ReproGO Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

ReproGO General Information

Description

Operator of a regenerative medicine company intended for stem cells and vascular biology-related drug development. The company aims to transform the treatment paradigm for patients grappling with severe and life-threatening conditions resulting from limited blood flow to tissues, enabling patients to undergo vascular therapies for reprogramming adult skin cells for use on CVD.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/O Qubis, 63 University Road
  • Belfast BT7 1NF
  • Northern Ireland, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • C/O Qubis, 63 University Road
  • Belfast BT7 1NF
  • Northern Ireland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReproGO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Nov-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
1. University Spin-Out 01-Jan-2020 Completed Startup
To view ReproGO’s complete valuation and funding history, request access »

ReproGO Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
To view ReproGO’s complete cap table history, request access »

ReproGO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ReproGO Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Business Connect Corporation Minority
QUBIS Venture Capital Minority
ICURe Accelerator/Incubator Minority
Queen's University Belfast University
College Green Ventures Venture Capital Minority
To view ReproGO’s complete investors history, request access »

ReproGO FAQs

  • When was ReproGO founded?

    ReproGO was founded in 2020.

  • Where is ReproGO headquartered?

    ReproGO is headquartered in Belfast, United Kingdom.

  • What is the size of ReproGO?

    ReproGO has 1 total employees.

  • What industry is ReproGO in?

    ReproGO’s primary industry is Drug Discovery.

  • Is ReproGO a private or public company?

    ReproGO is a Private company.

  • What is ReproGO’s current revenue?

    The current revenue for ReproGO is .

  • How much funding has ReproGO raised over time?

    ReproGO has raised $458K.

  • Who are ReproGO’s investors?

    Innovate UK Business Connect, QUBIS, ICURe, Queen's University Belfast, and College Green Ventures have invested in ReproGO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process